Abstract: Compounds of formula (I): wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
Type:
Application
Filed:
August 21, 2023
Publication date:
December 7, 2023
Applicant:
TARO PHARMACEUTICALS INC.
Inventors:
Curtis HARWIG, Jeremy D. PETTIGREW, Jennifer CROSS, Jeyaprakashnarayanan SEENISAMY, Mahesh Narayan KEREGADDE, Karthikeyan IYANAR
Abstract: Compounds of formula (1): wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
Type:
Grant
Filed:
May 23, 2022
Date of Patent:
October 3, 2023
Assignee:
Taro Pharmaceuticals Inc.
Inventors:
Curtis Harwig, Jeremy D. Pettigrew, Jennifer Cross, Jeyaprakashnarayanan Seenisamy, Mahesh Narayan Keregadde, Karthikeyan Iyanar
Abstract: Wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
Type:
Application
Filed:
February 17, 2023
Publication date:
June 29, 2023
Applicant:
TARO PHARMACEUTICALS INC.
Inventors:
Curtis HARWIG, Jeremy D. PETTIGREW, Jennifer CROSS, Jeyaprakashnarayanan SEENISAMY, Mahesh Narayan KEREGADDE, Samir Satish KHER, Karthikeyan IYANAR
Abstract: Compounds of formula (I) wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
Type:
Application
Filed:
August 4, 2022
Publication date:
January 5, 2023
Applicant:
TARO PHARMACEUTICALS INC.
Inventors:
Curtis HARWIG, Jeremy D. PETTIGREW, Jennifer CROSS, Jeyaprakashnarayanan SEENISAMY, Mahesh Narayan KEREGADDE, Samir Satish KHER
Abstract: Compounds of formula (1): wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
Type:
Application
Filed:
May 23, 2022
Publication date:
September 29, 2022
Applicant:
TARO PHARMACEUTICALS INC.
Inventors:
Curtis HARWIG, Jeremy D. PETTIGREW, Jennifer CROSS, Jeyaprakashnarayanan SEENISAMY, Mahesh Narayan KEREGADDE, Karthikeyan IYANAR
Abstract: Compounds of formula (I) wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
Type:
Grant
Filed:
April 5, 2019
Date of Patent:
August 23, 2022
Assignee:
TARO PHARMACEUTICALS INC.
Inventors:
Curtis Harwig, Jeremy D. Pettigrew, Jennifer Cross, Jeyaprakashnarayanan Seenisamy, Mahesh Narayan Keregadde, Samir Satish Kher
Abstract: Compounds of formula (I): wherein, R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.
Type:
Grant
Filed:
April 5, 2019
Date of Patent:
June 7, 2022
Assignee:
TARO PHARMACEUTICALS INC.
Inventors:
Curtis Harwig, Jeremy D. Pettigrew, Jennifer Cross, Jeyaprakashnarayanan Seenisamy, Mahesh Narayan Keregadde, Karthikeyan Iyanar